Recorded on September 5, 2018.
Elevian is a new company in partnership with Harvard, developing therapeutics that target regenerative capacity, the body’s ability to repair itself, which significantly declines with age. By targeting a fundamental mechanism of aging, Elevian’s medicines have the potential to treat or prevent many age-related diseases and extend healthy lifespan.
November 4
Boston
Get 50% off a second pass
Cover more ground at TechCrunch’s ultimate founder bootcamp of the year by bringing your co-founder or partner. Save 50% off a second pass. Meet scaling and investment leaders, ask questions, find solutions, and more.
Last day to save Oct. 16
